HYPR-Ad, as another oncolytic adenovirus that was developed through putting E1A under the control of a hypoxia/HIF-regulated promoter, causes cancer cell lysis under hypoxic conditions; they anticipated that HYPR-Ad could also kill cancer cells with an active hypoxia-inducible factor (HIF) during normoxia [79]. Here, DHTKD1 is linked to cancer.